ECRM_1170x120_8-1-17

A.T. Kearney

Houston’s retail, health and wellness scene under NACDS microscope

Houston’s retail, health and wellness scene under NACDS microscope

ARLINGTON, Va. — For just over 40 hours this week, the unique dynamics and national implications of Houston’s retail, health and wellness market will be under thorough examination by the NACDS Retail Advisory Board. The group – which evaluates CPG and retail topics and makes programming recommendations to the NACDS board of directors – brings its

The profit pool for U.S. prescription drugs is shrinking

The profit pool for U.S. prescription drugs is shrinking

For the past few years, the United States has been wrestling with the cost of health care. Our system is shifting toward outcomes-based payment models, and falling reimbursements are encouraging efficiency. As the industry seeks and implements lower-cost models, health care profitability is under pressure throughout the prescription drug value chain. To shed light on

A.T. Kearney study looks at the environmental impact on shopping

A.T. Kearney study looks at the environmental impact on shopping

CHICAGO —  Consumers are prepared to reward manufacturers, retailers, and others offering products that benefit the environment as long as any additional costs associated with providing those benefits are not transferred to them in the form of higher prices. Earth Day 2019, an A.T. Kearney study of 1,000 US consumers’ sentiments on environmental benefit claims found that more

CBD’s place in the chain drug merchandise mix

CBD’s place in the chain drug merchandise mix

Two thousand eighteen may be remembered in retail marketing history as the year discussing CBD moved from Bon-naroo to the board room.  Extensive media coverage; legalization of all forms of cannabis in Canada and parts of the U.S.; a tsunami of benefit claims; a flood of new CBD products across a broad spectrum of categories;

CBD: Assessing a nascent market

CBD: Assessing a nascent market

“The readiness is all.” It’s hard to think of an emerging product category where retailers and suppliers have taken Hamlet’s admonition more seriously than CBD. As attitudes about cannabis, hemp and products derived from them have shifted, and the legal and regulatory restrictions around them have started to unravel, many chains and an extensive roster

An introduction to the coming cannabis ‘gold rush’

An introduction to the coming cannabis ‘gold rush’

Editor’s note: This is Part I of an article that ran in the 1/21/19 issue of CDR. As legal cannabis-based products continue to find their way to market, promising to redefine entire categories from health, beauty and wellness to food and beverage in their wake, most chain drug retailers are scrambling to calculate the impact

A.T. Kearney acquires business analytics consultancy Cervello

A.T. Kearney acquires business analytics consultancy Cervello

CHICAGO — A.T. Kearney has acquired Cervello, an elite business analytics and data management consultancy. Operating as Cervello, an A.T. Kearney company, its team of data engineers, data scientists, and developers will work closely with Kearney client service teams worldwide to power client performance improvement and transformation programs with technology consulting, analytics, and data-driven insights.

Study: Consumers are ready to spend this holiday season

Study: Consumers are ready to spend this holiday season

CHIGACO — Holiday shoppers are more than prepared to buy in force this year.  The only question is who will capture their dollars. Three out of four consumers (76%) plan to spend as much or more than they did last year, but, according to A.T. Kearney’s 2018 Holiday Shopping Survey: How Retailers Can Capitalize on

New technologies: opportunities and challenges

New technologies: opportunities and challenges

Editor’s note: The second in a series of seven articles by A.T. Kearney on the trends that are radically transforming the health sector. There is no question that science is rapidly accelerating the health care opportunities we see in the marketplace. Broader genetics capabilities could mean new services and treatments based on genetic makeup that

A.T. Kearney study shows consumers would try a legal cannabis therapeutic product

A.T. Kearney study shows consumers would try a legal cannabis therapeutic product

CHICAGO — Recent research by A.T. Kearney into American and Canadian consumer attitudes toward legalized cannabis revealed that more than three-quarters (76%) would try medicinal cannabis products and about half would try cannabis-enhanced consumer products such as snack foods (55%), nutritional supplements (50%) and cosmetics (43%). While North American attitudes toward marijuana are relaxing almost as

What to do about mounting transportation costs

What to do about mounting transportation costs

The high value of pharmaceutical shipments has traditionally meant that all parties in the chain drug industry were primarily concerned with quality. They needed a reliable, transparent solution. Given that shipping represented a tiny percentage of drug costs, price was a lesser concern. But recently shipping rates have increased sharply. Is there anything the industry

Connecting the dots in payment ecosystem

Connecting the dots in payment ecosystem

We are now more than 20 years into the e-commerce era of retail. As many brick-and-mortar retail sectors have found creative ways to combat the online threat, pharmacy chains too are identifying the most effective solutions. One area that offers an opportunity for improvement is payments. For digitally savvy customers, the checkout experience — the

Crowdsourced network design transforms logistics

Crowdsourced network design transforms logistics

A perfect storm is brewing for drug retailers’ supply chain managers, third-party logistics suppliers (3PLs) and the carriers they work with. After U.S. logistics costs declined 1.5% in 2016, the first half of 2017 was flat due to lingering overcapacity and rate pressures that had shippers asking for — and still getting — rate reductions.

1 2 3 4